Literature DB >> 24215866

Metastasis-associated protein S100A4 induces a network of inflammatory cytokines that activate stromal cells to acquire pro-tumorigenic properties.

Ingrid J Bettum1, Kotryna Vasiliauskaite1, Vigdis Nygaard1, Trevor Clancy1, Solveig J Pettersen1, Ellen Tenstad2, Gunhild M Mælandsmo3, Lina Prasmickaite4.   

Abstract

Tumor cells have the ability to exploit stromal cells to facilitate metastasis. By using malignant melanoma as a model, we show that the stroma adjacent to metastatic lesions is enriched in the known metastasis-promoting protein S100A4. S100A4 stimulates cancer cells to secrete paracrine factors, such as inflammatory cytokines IL8, CCL2 and SAA, which activate stromal cells (endothelial cells and monocytes) so that they acquire tumor-supportive properties. Our data establishes S100A4 as an inducer of a cytokine network enabling tumor cells to engage angiogenic and inflammatory stromal cells, which might contribute to pro-metastatic activity of S100A4.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cytokines; Melanoma; Metastasis; S100A4; Tumor-stroma interactions

Mesh:

Substances:

Year:  2013        PMID: 24215866     DOI: 10.1016/j.canlet.2013.10.036

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  17 in total

1.  TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.

Authors:  Marijana Kovačić; Olivera Mitrović-Ajtić; Bojana Beleslin-Čokić; Dragoslava Djikić; Tijana Subotički; Miloš Diklić; Danijela Leković; Mirjana Gotić; Pascal Mossuz; Vladan P Čokić
Journal:  Cell Oncol (Dordr)       Date:  2018-06-26       Impact factor: 6.730

Review 2.  Out of the frying pan and into the fire: damage-associated molecular patterns and cardiovascular toxicity following cancer therapy.

Authors:  Nicole S Klee; Cameron G McCarthy; Patricia Martinez-Quinones; R Clinton Webb
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-09-15

3.  Endocrine MPA enhances the effects of TAC chemotherapy on improvement of prognosis and increase in long-term survival rates for patients with endometrial cancer.

Authors:  Xiuhong Yuan; L U Wang; Juan Xue; L I Li; Jing Zhang
Journal:  Oncol Lett       Date:  2015-06-19       Impact factor: 2.967

4.  S100A4 promotes inflammation but suppresses lipid accumulation via the STAT3 pathway in chronic ethanol-induced fatty liver.

Authors:  Qi Yuan; Shasha Hou; Junfeng Zhai; Tian Tian; Yingjie Wu; Zhenlong Wu; Jinsheng He; Zhinan Chen; Jinhua Zhang
Journal:  J Mol Med (Berl)       Date:  2019-07-18       Impact factor: 4.599

Review 5.  S100 proteins in cancer.

Authors:  Anne R Bresnick; David J Weber; Danna B Zimmer
Journal:  Nat Rev Cancer       Date:  2015-02       Impact factor: 60.716

Review 6.  Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.

Authors:  Ashleigh R Poh; Robert J J O'Donoghue; Matthias Ernst
Journal:  Oncotarget       Date:  2015-06-30

7.  The S100A4 D10V polymorphism is related to cell migration ability but not drug resistance in gastric cancer cells.

Authors:  Tein-Ming Yuan; Ruei-Yue Liang; Nai-Wan Hsiao; Show-Mei Chuang
Journal:  Oncol Rep       Date:  2014-10-13       Impact factor: 3.906

Review 8.  Damage-associated molecular patterns in cancer: a double-edged sword.

Authors:  C Hernandez; P Huebener; R F Schwabe
Journal:  Oncogene       Date:  2016-04-18       Impact factor: 9.867

Review 9.  Examination of Epigenetic and other Molecular Factors Associated with mda-9/Syntenin Dysregulation in Cancer Through Integrated Analyses of Public Genomic Datasets.

Authors:  Manny D Bacolod; Swadesh K Das; Upneet K Sokhi; Steven Bradley; David A Fenstermacher; Maurizio Pellecchia; Luni Emdad; Devanand Sarkar; Paul B Fisher
Journal:  Adv Cancer Res       Date:  2015-05-23       Impact factor: 6.242

10.  Increased expression levels of S100A4 associated with hypoxia-induced invasion and metastasis in esophageal squamous cell cancer.

Authors:  Xiaoyan Xuan; Qianru Li; Zhongning Zhang; Ying Du; Pingping Liu
Journal:  Tumour Biol       Date:  2014-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.